Overview

Detailed Summary

Amanta Healthcare Limited is a fully integrated sterile liquids pharmaceutical manufacturer and marketer focused on Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), using ABFS and ISBM technologies from a WHO‑GMP certified facility in Gujarat, with a 47-product portfolio, 320 distributors, and exports to 21 countries.
The company is mid-inflection: FY25 revenues were INR275 crore and PAT turned positive to INR11 crore after prior losses, with a historical revenue CAGR of 11.8% (FY21–25); management targets a materially higher 20%+ CAGR over the next two years driven by capacity additions and product mix improvement.
SteriPort®, Amanta’s differentiated two‑port ISBM polypropylene container, is the core revenue driver at ~40–44% of revenues and operates at high utilization (91%), giving the company pricing discipline, perceived sterility advantages over polyethylene containers, and a leadership position in the two‑port IV fluids niche.
Near-term value drivers are capital‑led and operational: a large FY26 capex program (~INR130 crore) to add SteriPort and SVP capacity, plus a 10.8 MW captive solar plant (INR34.8 crore) expected to save ~INR9 crore annually, combined with a conservative FY27 revenue target near INR400 crore and margin expansion to mid‑20s percent EBITDA.
Balance sheet momentum is visible: the company has reduced borrowings and debt‑to‑equity materially from FY23 levels, repaid higher‑coupon instruments, completed an IPO and private placement (INR20 crore), and is prioritizing accelerated deleveraging even while funding expansion.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 518 Cr
Volatility: Low Risk
P/E Ratio: 34.8
Industry P/E: 33.7
PEG Ratio: 0.2
P/B Ratio: 2.3
52W High: 154.85
52W Low: 93.10

Sales CAGR

1Y: -2.01%
3Y: 6.81%
5Y: 8.30%
10Y: —

Profit CAGR

1Y: 189.26%
3Y: -42.46%
5Y: —
10Y: —

ROE

TTM: 7.46%
3Y: 5.33%
5Y: 14.84%
10Y: —

ROCE

TTM: 9.58%
3Y: 15.07%
5Y: 18.74%
10Y: —

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
KILITCH		165.00	585 Cr	19.38	2.09	0.00	10.79	12.00	6.44
ZIMLAB		103.45	554 Cr	94.69	1.89	0.00	1.97	5.07	1.08
INFLUX		232.65	539 Cr	26.23	5.35	0.00	20.38	27.21	0.00
JENBURPH		1159.70	512 Cr	14.74	2.60	1.78	17.63	23.20	15.37
AMANTA		130.05	509 Cr	34.21	2.31	0.00	7.46	9.58	2.67
BAFNAPH		196.60	465 Cr	41.90	4.84	0.00	11.54	10.63	6.32
HALEOSLABS		1356.70	410 Cr	23.68	1.92	0.00	8.11	9.76	3.92
Median: 7 Co.	—	196.60	512 Cr	26.23	2.31	0.00	10.79	10.63	3.92

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	68	67	68	72	65	71	74	77
Expenses	55	53	53	53	50	56	59	62
Operating Profit	13	14	15	19	15	15	15	15
OPM %	19.68	20.80	22.21	26.31	22.81	20.67	20.62	19.42
Other Income	0.15	0.21	0.87	0.16	0.96	-2.56	0.68	1.66
Interest	9.45	6.32	5.90	6.28	6.29	5.15	5.06	4.25
Depreciation	4.60	4.60	4.51	4.69	4.64	4.66	4.67	4.75
Profit Before Tax	-0.50	3.17	5.53	8.15	4.93	2.28	6.30	7.62
Tax %	28.00	28.71	22.60	26.87	28.80	46.93	26.51	27.43
Net Profit	-0.36	2.26	4.28	5.96	3.51	1.21	4.63	5.53
EPS in Rs	—	0.59	—	—	1.22	0.35	1.35	1.61

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	184	171	225	259	280	275
Expenses	147	133	173	206	223	215
Operating Profit	37	38	52	53	57	60
OPM %	20.27	22.38	23.09	20.35	20.51	21.72
Other Income	2.13	1.06	76	3.57	1.27	1.39
Interest	38	40	49	35	34	28
Depreciation	16	17	17	18	20	18
Profit Before Tax	-15	-18	62	2.69	5.39	15
Tax %	-24.84	-22.97	11.02	178.46	32.58	28.60
Net Profit	-19	-22	55	-2.11	3.63	11
EPS in Rs	—	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	27	27	27	27	27	29
Reserves	2.27	-20	36	36	39	68
Borrowings	227	196	226	216	205	204
Other Liabilities	132	189	104	96	81	81
Total Liabilities	388	392	392	374	352	382
Fixed Assets	244	242	240	229	223	217
CWIP	0.00	0.00	0.00	8.80	5.41	6.55
Investments	0.10	1.50	3.25	3.47	3.72	7.72
Other Assets	144	149	149	133	120	150
Total Assets	388	392	392	374	352	382

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	38	33	62	43	58	47
Cash from Investing Activity	-9.33	-16	-6.05	-6.53	-10	-24
Cash from Financing Activity	-37	-18	-50	-42	-46	-23
Net Cash Flow	-8.14	-0.18	5.50	-6.27	1.43	-1.32

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2024	Feb 2025	Jun 2025	Aug 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	85.52%	85.52%	63.56%	85.60%	63.56%	63.56%	63.72%
FIIs	0.00%	0.00%	2.21%	0.00%	2.21%	1.10%	0.85%
DIIs	14.48%	14.48%	12.22%	14.40%	12.22%	11.24%	12.88%
Public	0.00%	0.00%	22.02%	0.00%	22.02%	24.10%	22.56%
Total Shareholders	192	200	30,695	361	30,695	16,181	15,222

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Amanta Healthcare Ltd

Amanta Healthcare Ltd (AMANTA) is currently trading at 133.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Amanta Healthcare Limited is a fully integrated sterile liquids pharmaceutical manufacturer and marketer focused on Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), using ABFS and ISBM technologies from a WHO‑GMP certified facility in Gujarat, with a 47-product portfolio, 320 distributors, and exports to 21 countries. The company is mid-inflection: FY25 revenues were INR275 crore and PAT turned positive to INR11 crore after prior losses, with a historical revenue CAGR of 11.8% (FY21–25); management targets a materially higher 20%+ CAGR over the next two years driven by capacity additions and product mix improvement. SteriPort®, Amanta’s differentiated two‑port ISBM polypropylene container, is the core revenue driver at ~40–44% of revenues and operates at high utilization (91%), giving the company pricing discipline, perceived sterility advantages over polyethylene containers, and a leadership position in the two‑port IV fluids niche. Near-term value drivers are capital‑led and operational: a large FY26 capex program (~INR130 crore) to add SteriPort and SVP capacity, plus a 10.8 MW captive solar plant (INR34.8 crore) expected to save ~INR9 crore annually, combined with a conservative FY27 revenue target near INR400 crore and margin expansion to mid‑20s percent EBITDA. Balance sheet momentum is visible: the company has reduced borrowings and debt‑to‑equity materially from FY23 levels, repaid higher‑coupon instruments, completed an IPO and private placement (INR20 crore), and is prioritizing accelerated deleveraging even while funding expansion.

Over the past 52 weeks, Amanta Healthcare Ltd has traded between a low of ₹93.10 and a high of ₹154.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Amanta Healthcare Ltd has a market capitalization of approximately 509.05. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Amanta Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 34.21 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 509.05 Cr, Amanta Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Amanta Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Amanta Healthcare Ltd is 34.21. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The IPO was stated as a ₹126 crore book-built issue and entirely a fresh issue, with total issue size shown as 1,00,00,000 shares aggregating up to ₹126 crore.

Amanta Healthcare Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Amanta Healthcare Ltd

What is Amanta Healthcare Ltd share price today?

What does Amanta Healthcare Ltd do?

What is the 52-week high and low of Amanta Healthcare Ltd?

What is the market capitalization of Amanta Healthcare Ltd?

Should I consider investing in Amanta Healthcare Ltd stock?

Is Amanta Healthcare Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Amanta Healthcare Ltd belong to and why does it matter?

What is the PE ratio of Amanta Healthcare Ltd?

What was the issue size of the Amanta Healthcare IPO?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Amanta Healthcare Ltd

What is Amanta Healthcare Ltd share price today?

What does Amanta Healthcare Ltd do?

What is the 52-week high and low of Amanta Healthcare Ltd?

What is the market capitalization of Amanta Healthcare Ltd?

Should I consider investing in Amanta Healthcare Ltd stock?

Is Amanta Healthcare Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Amanta Healthcare Ltd belong to and why does it matter?

What is the PE ratio of Amanta Healthcare Ltd?

What was the issue size of the Amanta Healthcare IPO?

Peers

Price Chart Comparison

Investment Checklist

Overview

Financial Ratios

Oscillators

Neutral

Overall

Bullish

Moving Averages

Bullish

Overall

Bullish

Announcements